文献速递细菌感染、耐药与抗菌药物医院感染防控

多重耐药菌定植对实体器官移植受者移植物存活、感染风险及死亡率的影响:系统综述与荟萃分析

The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2024-04-10

该系统综述与荟萃分析纳入15,202例实体器官移植受者(33项队列研究和6项病例对照研究),评估多重耐药菌定植对移植后死亡、感染及移植物丢失的影响。结果显示,多重耐药菌定植显著增加移植后1年死亡率(OR 2.35,95%CI 1.63-3.38)和混合感染风险(OR 10.74,95%CI 7.56-12.26),但对移植物丢失无显著影响(p=0.41,I²=0)。作者认为,尽管证据确定性低,仍有必要采取行动预防移植候选者的多重耐药菌定植。

要点

  • 多重耐药菌定植显著增加实体器官移植受者移植后1年死亡率(OR 2.35,95%CI 1.63-3.38)。
  • 多重耐药菌定植显著增加混合感染风险(OR 10.74,95%CI 7.56-12.26),对移植物丢失无显著影响(p=0.41)。
  • 碳青霉烯类耐药肠杆菌目定植与结局关联更强(死亡OR 3.94,混合感染OR 24.8)。

核心结论

  • 实体器官移植受者多重耐药菌定植,尤其是碳青霉烯类耐药肠杆菌目定植,与死亡率增加相关。
  • 尽管证据确定性低,仍有必要采取行动预防移植候选者的多重耐药菌定植。

研究设计与样本

  • 系统综述与荟萃分析,检索PROSPERO、OVID Medline、OVID EMBASE、Wiley Cochrane Library、ProQuest Dissertations and Theses Global及SCOPUS,从建库至2023年3月20日。
  • 研究方案注册于PROSPERO(CRD42022290011),遵循PRISMA指南。
  • 纳入报告成人实体器官移植受者定植于耐甲氧西林金黄色葡萄球菌、耐万古霉素肠球菌、产超广谱β-内酰胺酶或碳青霉烯类耐药肠杆菌目、或多重耐药假单胞菌的队列研究和病例对照研究,并与非定植者比较。
  • 共纳入15,202例实体器官移植受者(33项队列研究、6项病例对照研究),肝移植和耐万古霉素肠球菌定植(分别为25项和14项研究)为主。
  • 两名评审员评估纳入资格,使用纽卡斯尔-渥太华量表进行偏倚风险评估,并采用GRADE方法评级证据确定性。

主要发现

  • 多重耐药菌定植显著增加移植后1年死亡率(OR 2.35,95%CI 1.63-3.38;p<0.001,I²=58%)和混合感染风险(OR 10.74,95%CI 7.56-12.26),跨移植类型。
  • 多重耐药菌定植对移植物丢失无显著影响(p=0.41,I²=0)。
  • 亚组分析显示,碳青霉烯类耐药肠杆菌目定植与结局关联更强:死亡OR 3.94,混合感染OR 24.8;产超广谱β-内酰胺酶定植混合感染OR 10.3,无死亡率数据。
  • 耐甲氧西林金黄色葡萄球菌定植:死亡OR 2.25,混合感染OR 7.75;耐万古霉素肠球菌定植:死亡p=0.20,混合感染OR 5.71。

关键数值与推荐

  • 多重耐药菌定植增加移植后1年死亡率:OR 2.35(95%CI 1.63-3.38)。
  • 多重耐药菌定植增加混合感染风险:OR 10.74(95%CI 7.56-12.26)。
  • 碳青霉烯类耐药肠杆菌目定植与死亡关联:OR 3.94;与混合感染关联:OR 24.8。
  • 产超广谱β-内酰胺酶定植与混合感染关联:OR 10.3。
  • 耐甲氧西林金黄色葡萄球菌定植与死亡关联:OR 2.25;与混合感染关联:OR 7.75;耐万古霉素肠球菌定植与混合感染关联:OR 5.71。

临床怎么用

  • 作者认为,尽管证据确定性低,仍有必要采取行动预防移植候选者的多重耐药菌定植。

局限性

  • 证据确定性低(GRADE评级)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Global increase in colonization by multidrug-resistant (MDR) bacteria poses a significant concern. The precise impact of MDR colonization in solid organ transplant recipients (SOTR) remains not well established. OBJECTIVES: To assess the impact of MDR colonization on SOTR's mortality, infection, or graft loss. METHODS AND DATA SOURCES: Data from PROSPERO, OVID Medline, OVID EMBASE, Wiley Cochrane Library, ProQuest Dissertations, Theses Global, and SCOPUS were systematically reviewed, spanning from inception until 20 March 2023. The study protocol was registered with PROSPERO (CRD42022290011) and followed the PRISMA guidelines. STUDY ELIGIBILITY CRITERIA, PARTICIPANTS, INTERVENTIONS, AND ASSESSMENT OF RISK OF BIAS: Cohorts and case-control studies that reported on adult SOTR colonized by Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum β-lactamase (ESBL) or carbapenem-resistant Enterobacteriaceae. (CRE), or MDR-pseudomonas, and compared to noncolonized, were included. Two reviewers assessed eligibility, conducted a risk of bias evaluation using the Newcastle-Ottawa Scale, and rated certainty of evidence using the GRADE approach. METHODS OF DATA SYNTHESIS: We employed RevMan for a meta-analysis, using random-effects models to compute pooled odds ratios (OR) and 95% confidence intervals (CI). Statistical heterogeneity was determined using the I2 statistic. RESULTS: 15,202 SOTR (33 cohort, six case-control studies) were included, where liver transplant and VRE colonization (25 and 14 studies) were predominant. MDR colonization significantly increased posttransplant 1-year mortality (OR, 2.35; 95% CI, 1.63-3.38) and mixed infections (OR, 10.74; 95% CI, 7.56-12.26) across transplant types (p < 0.001 and I2 = 58%), but no detected impact on graft loss (p 0.41, I2 = 0). Subgroup analysis indicated a higher association between CRE or ESBL colonization with outcomes (CRE: death OR, 3.94; mixed infections OR, 24.8; ESBL: mixed infections OR, 10.3; no mortality data) compared to MRSA (Death: OR, 2.25; mixed infection: OR, 7.75) or VRE colonization (Death: p 0.20, mixed infections: OR, 5.71). CONCLUSIONS: MDR colonization in SOTR, particularly CRE, is associated with increased mortality. Despite the low certainty of the evidence, actions to prevent MDR colonization in transplant candidates are warranted.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Almohaya A, Fersovich J, Weyant RB, et al. The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis. Clin Microbiol Infect. 2024. PMID: 38608872. doi:10.1016/j.cmi.2024.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。